Skip to main content
Login
User menu
Mega menu
EASL
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Policy Dialogues
EASL Quiz
ePosters
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - International Liver Congress
Industry Symposia - Liver Cancer Summit
Industry Symposia - NAFLD Summit 2022
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab
Created on
23 Apr 2024
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
EASL Molecular Tumour Board on intrahepatic cholangiocarcinoma
Created on
12 Mar 2024
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
YI Afterwork Series – Navigating through an academic career: Step-by-step
Created on
13 Feb 2024
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
Webinar: Steatotic liver disease – the missing piece in the NCD puzzle
Created on
31 Jan 2024
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
Molecular Tumour Board in HCC: Is it possible and/or practical?
Created on
14 Nov 2023
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
Inflamed and non-inflamed class of HCC: A revised immunogenomic classification
Created on
31 Oct 2023
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
EASL Molecular Tumour Board on intrahepatic cholangiocarcinoma
Created on
23 May 2023
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Created on
09 May 2023
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
EASL YI Afterwork Series: Live(r) Webinar on Translational Research
Created on
16 Mar 2023
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
Live(r) webinar on Translational Research
Created on
16 Feb 2023
•
by
Anonymous (not verified)
Total amount of likes
0
Total amount of comments
0
Pagination
Current page
1
Page
2
Page
3
Next page
Next ›
Last page
Last »
Subscribe to
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Privacy Policy
Cookie Policy